In the Fall of 2019 a sudden and dramatic outbreak of a pulmonary disease (Coronavirus
Disease COVID-19), due to a new Coronavirus strain (ie, SARS-CoV-2), emerged in the …

Epidemiological data shows a discrepancy in COVID‐19 susceptibility and outcomes with
some regions being more heavily affected than others. However, the factors that determine …

Plasmepsin II is a key enzyme in the life cycle of the Plasmodium falciparum parasite
responsible for malaria, a disease that is causing deaths on a worldwide scale. Recently …

Abstract Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has been
responsible for the cause of global pandemic Covid-19 and to date, there is no effective …

The disease caused by viral pneumonia called severe acute respiratory syndrome
coronavirus type-2 (SARS-CoV-2) declared by the World Health Organization is a global …

Introduction The aim of this study was to assess the efficacy and safety of a combination of
bromhexine at a dose of 8 mg 4 times a day and spironolactone 50 mg per day in patients …

Результаты открытого проспективного контролируемого сравнительного исследования по
лечению новой коронавирусной инфекции (COVID-19): Бромгексин И Спиронолактон для …

COVID-19 pandemic caused by the SARS-CoV-2 virus has led to a worldwide crisis. In view
of emerging variants time to time, there is a pressing need of effective COVID-19 …

SARS-CoV-2, responsible for the COVID-19 pandemic, invades host cells via its spike
protein, which includes critical binding regions, such as the receptor-binding domain (RBD) …

A coronavirus disease pandemic (COVID-19) is still a global problem with not sufficient
evidence of a declining pattern caused by severe acute respiratory syndrome coronavirus 2 …